KUALA LUMPUR, July 26 (Bernama) — Clinical Research Malaysia (CRM) inked an education scholarship agreement with the Ministry of Health (MOH) and National Pharmaceutical Regulatory Agency (NPRA) earlier today at CRM headquarters. Under the agreement, CRM will be sponsoring two NPRA officers to pursue their Master’s program in Clinical Pharmacology at King’s College London.
The initiative is aligned with CRM’s Phase 1 Realisation Project (P1RP) 2.0, which focuses on further enhancing Malaysia’s capabilities on early phase/first-in-human trials. The project is an extension of the initial P1RP program launched in 2016 in which three NPRA officers and a Medical Oncologist from Sarawak General Hospital were sponsored for postgraduate studies and fellowship attachment respectively, at renowned global institutions, to build their expertise in early phase trials. Investment in human capital development is a continuous effort taken by CRM, an organization wholly-owned by the MOH, to ensure the country’s readiness for safe and high-quality conduct of clinical trials.